First Trust Advisors LP Boston Scientific Corp Transaction History

First Trust Advisors LP

  • $101 Billion
  • Q3 2024

A detailed history of First Trust Advisors LP transactions in Boston Scientific Corp stock. As of the latest transaction made, First Trust Advisors LP holds 196,212 shares of BSX stock, worth $17.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
196,212
Previous 335,909 41.59%
Holding current value
$17.8 Million
Previous $25.9 Million 36.44%
% of portfolio
0.02%
Previous 0.03%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$72.96 - $84.0 $10.2 Million - $11.7 Million
-139,697 Reduced 41.59%
196,212 $16.4 Million
Q2 2024

Aug 13, 2024
BUY
$67.33 - $77.71 $16.3 Million - $18.8 Million
242,140 Added 258.23%
335,909 $25.9 Million
Q1 2024

May 13, 2024
SELL
$57.6 - $68.62 $800,006 - $953,063
-13,889 Reduced 12.9%
93,769 $6.42 Million
Q4 2023

Feb 13, 2024
SELL
$48.64 - $57.81 $3.2 Million - $3.8 Million
-65,724 Reduced 37.91%
107,658 $6.22 Million
Q3 2023

Nov 13, 2023
SELL
$50.19 - $54.68 $889,266 - $968,820
-17,718 Reduced 9.27%
173,382 $9.15 Million
Q2 2023

Aug 14, 2023
BUY
$49.72 - $54.64 $9.5 Million - $10.4 Million
191,100 New
191,100 $10.3 Million
Q2 2022

Aug 12, 2022
SELL
$35.24 - $47.1 $1.36 Million - $1.81 Million
-38,512 Reduced 21.48%
140,794 $5.25 Million
Q1 2022

May 13, 2022
BUY
$40.9 - $45.1 $5.98 Million - $6.6 Million
146,237 Added 442.22%
179,306 $7.94 Million
Q4 2021

Feb 08, 2022
SELL
$38.07 - $44.87 $190,007 - $223,946
-4,991 Reduced 13.11%
33,069 $1.41 Million
Q3 2021

Nov 15, 2021
SELL
$41.23 - $45.88 $5.39 Million - $5.99 Million
-130,613 Reduced 77.44%
38,060 $1.65 Million
Q2 2021

Aug 16, 2021
SELL
$38.58 - $44.24 $23.3 Million - $26.7 Million
-603,873 Reduced 78.17%
168,673 $7.21 Million
Q1 2021

May 14, 2021
SELL
$35.27 - $39.67 $117 Million - $131 Million
-3,313,586 Reduced 81.09%
772,546 $29.9 Million
Q4 2020

Feb 02, 2021
BUY
$33.15 - $41.97 $117 Million - $148 Million
3,523,734 Added 626.56%
4,086,132 $147 Million
Q3 2020

Nov 05, 2020
BUY
$34.44 - $42.23 $13.8 Million - $16.9 Million
399,858 Added 246.01%
562,398 $21.5 Million
Q2 2020

Jul 22, 2020
SELL
$30.19 - $39.11 $3.31 Million - $4.29 Million
-109,611 Reduced 40.28%
162,540 $5.71 Million
Q1 2020

May 06, 2020
SELL
$25.83 - $45.71 $39.1 Million - $69.1 Million
-1,512,483 Reduced 84.75%
272,151 $8.88 Million
Q4 2019

Feb 03, 2020
SELL
$37.87 - $45.37 $838,441 - $1 Million
-22,140 Reduced 1.23%
1,784,634 $80.7 Million
Q3 2019

Nov 04, 2019
BUY
$40.31 - $43.45 $59.1 Million - $63.7 Million
1,466,762 Added 431.39%
1,806,774 $73.5 Million
Q2 2019

Jul 30, 2019
SELL
$34.91 - $42.98 $36.6 Million - $45 Million
-1,048,160 Reduced 75.51%
340,012 $14.6 Million
Q1 2019

May 09, 2019
BUY
$32.91 - $40.75 $6.72 Million - $8.32 Million
204,129 Added 17.24%
1,388,172 $53.3 Million
Q4 2018

Feb 07, 2019
BUY
$31.73 - $39.04 $11 Million - $13.5 Million
346,861 Added 41.43%
1,184,043 $41.8 Million
Q3 2018

Oct 25, 2018
BUY
$32.83 - $38.63 $18.7 Million - $22 Million
569,429 Added 212.67%
837,182 $32.2 Million
Q2 2018

Aug 02, 2018
BUY
$26.84 - $34.32 $6.67 Million - $8.54 Million
248,695 Added 1304.94%
267,753 $8.76 Million
Q1 2018

Apr 23, 2018
SELL
$25.2 - $28.54 $12.2 Million - $13.9 Million
-485,367 Reduced 96.22%
19,058 $521,000
Q4 2017

Feb 08, 2018
SELL
$24.79 - $29.8 $8.23 Million - $9.89 Million
-331,971 Reduced 39.69%
504,425 $12.5 Million
Q3 2017

Oct 24, 2017
BUY
$26.26 - $29.17 $22 Million - $24.4 Million
836,396
836,396 $24.4 Million

Others Institutions Holding BSX

# of Institutions
1,542
Shares Held
1.19B
Call Options Held
6.79M
Put Options Held
10.1M
View Full List

About BOSTON SCIENTIFIC CORP

BSX Quotes by TradingView
  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email